क्यूआर कोड

HLA class-I genotyping to personalize Bacille Calmette–Guerin immunotherapy in bladder cancer

Bacille Calmette-Guerin (BCG) is the immunotherapy of choice for high-risk non-muscle invasive bladder cancer (BC), although recurrence eventually occurs in 50% of patients and 20% progress to advanced stages. This study evaluates the predictive value of human leukocyte antigen class-I (HLA-I) genot...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Inmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, Pedro López Cubillana, Tomás Fernández Aparicio, Lucas Jesús Asensio Egea, Juan Moreno Avilés, Gloria Doñate Iñiguez, Pablo Luis Guzmán Martínez-Valls, Gerardo Server, Belén Ferri, José Antonio Campillo, Francisco Galindo, María Victoria Martínez-Sánchez, Alfredo Minguela
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Taylor & Francis Group 2025-12-01
श्रृंखला:OncoImmunology
विषय:
Bladder cancer
Bacille Calmette-Guerin
immunotherapy
NK cells
HLA
ऑनलाइन पहुंच:https://www.tandfonline.com/doi/10.1080/2162402X.2025.2598920
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन